4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow Port-Wine Stain: new trials by email Literature Review of Port-Wine Stain trials Research Report on Port-Wine Stain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pilot Study of Hemoporfin PDT in Children(2-7 Years Old) With Port-wine Stain Hemoporfin PDT - Port-wine Stain | Phase 4 | Completed | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 40 | 2020-05-27 | 2023-12-20 |
| A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology Haemoblock, Placebo - Vascular Diseases, Vascular Malformation | Phase 4 | Completed | Center for Vascular Pathology, Moscow | 200 | 2020-01-01 | 2021-11-04 |
| Postmarketing Safety Study of Hemoporfin in Patients With Port Wine Stain Hemoporfin - Port-Wine Stain | Phase 4 | Completed | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 501 | 2017-08-31 | 2023-12-20 |
| A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain Hemoporfin PDT - Port-wine Stain | Phase 4 | Completed | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 24 | 2017-08-02 | 2020-08-13 |
Capillary Malformation-Arteriovenous Malformation (1) · Capillary Malformations, Congenital, 1 (1) · Sturge-Weber Syndrome (1) · Vascular Diseases (1) · Vascular Malformations (1) · Vascular Neoplasms (1)
Congenital Abnormalities (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Skin Abnormalities (4) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Angiomatosis (1) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Hemangioma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Vascular Tissue (1) · Nervous System Diseases (1) · Neurocutaneous Syndromes (1)
hematoporphyrin monomethyl ether (1)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (3) · Center for Vascular Pathology, Moscow (1)
China (3) · Russia (1)
Jining Tao (2) · Alexander Plotkin, PhD (1) · Dmitry V Romanov, MD (1) · Ekaterina M Listovskaya, BSc (1) · Lin Ma, MD (1) · Xuejun Zhu (1)